Market cap
₹43 Cr
Market cap
₹43 Cr
Revenue (TTM)
₹127 Cr
P/E Ratio
22.5
P/B Ratio
2.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹2 Cr
ROE
12.3 %
ROCE
12.1 %
Industry P/E
27.94
EV/EBITDA
11.7
Debt to Equity
1.9
Book Value
₹24.2
EPS
₹2.5
Face value
10
Shares outstanding
7,865,520
CFO
₹-0.69 Cr
EBITDA
₹21.68 Cr
Net Profit
₹8.51 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Roopa
| 25.4 | 23.0 | 24.1 | -2.4 | -3.4 | 40.3 | 22.3 |
|
BSE Commodities
| 5.1 | 15.1 | 5.2 | 14.0 | 18.0 | 13.5 | 16.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Roopa
| -39.6 | 43.0 | -5.4 | 132.1 | 85.5 | 26.4 | -24.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Roopa
|
55.2 | 43.4 | 127.2 | 1.9 | 3.7 | 10.8 | 22.5 | 2.3 |
| 6,680.5 | 19,702.9 | 6,273.5 | 683.0 | 11.3 | 11.2 | 29.1 | 3.2 | |
| 1,187.1 | 18,510.4 | 13,910.2 | 664.1 | 7.7 | 9.8 | 27.9 | 2.5 | |
| 845.1 | 15,043.7 | 37,474.8 | 2,223.8 | 7.2 | 12.8 | 12.6 | 1.7 | |
| 4,710.3 | 3,541.3 | 604.0 | 75.2 | 15.9 | 11.6 | 49 | -- | |
| 72.9 | 3,312.2 | 1,175.2 | 140.3 | 11.9 | 14.5 | 23.6 | 3.2 | |
| 963.3 | 6,458.0 | 9,655.3 | 225.1 | 5.0 | 11.6 | 23.9 | 2.2 | |
| 638.2 | 3,945.5 | 2,418.0 | 180.1 | 10.9 | 35.8 | 21.9 | 7.0 | |
| 506.9 | 4,441.4 | 1,867.0 | 150.2 | 10.2 | 29.8 | 29.6 | 8.1 | |
| 1,634.5 | 4,471.0 | 818.2 | 19.4 | 12.6 | 3.7 | 226.6 | 4.6 |
No Review & Analysis are available.
Roopa Industries Limited manufactures, markets, and sells nutraceuticals, bulk drugs, and fine chemicals in India. The company offers glucosamine, a nutraceutical/nutritional supplement that is used for the treatment of arthritis; and triphenyl... phosphine, which have applications in antibiotics, statins, specialty resins/paints, fire retardants, phosphonium salts, phase transfer catalysts, agriculture related products, etc., as well as in organic synthesis. It also provides bromine and bromine compounds, including meta bromo anisole, tetra butyl ammonium bromide, 1-bromo-3-chloropropane, 1-acetoxy ethyl bromide, etc., which are used in chemical and pharmaceutical industries; sildenafil citrate; and losartan potassium. The company also offers its products in the United States, Japan, and the European Union. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India. Read more
Incorporated
1985
Chairman
Tumbalam Gooty Raghavendra
Managing Director
Tumbalam Gooty Raghavendra
Group
TG Venkatesh
Headquarters
Kurnool Dist, Andhra Pradesh
Website
Annual Reports
The share price of Roopa Industries Ltd is ₹55.23 (BSE) as of 24-Apr-2026 IST. Roopa Industries Ltd has given a return of -3.43% in the last 3 years.
The P/E ratio of Roopa Industries Ltd is 22.47 times as on 24-Apr-2026, a 20 discount to its peers’ median range of 27.94 times.
The P/B ratio of Roopa Industries Ltd is 2.29 times as on 24-Apr-2026, a 17 discount to its peers’ median range of 2.76 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
19.78
|
2.30
|
|
2024
|
30.64
|
3.01
|
|
2023
|
23.89
|
2.31
|
|
2022
|
19.37
|
1.56
|
|
2021
|
10.28
|
0.64
|
The 52-week high and low of Roopa Industries Ltd are Rs 71.99 and Rs 38.10 as of 25-Apr-2026.
Roopa Industries Ltd has a market capitalisation of ₹ 43 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Roopa Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.